PTPN1 and obesity disorder: Interestingly, in the course of this study, we had discovered that hyrtiosal could inhibit not only PTP1B (protein tyrosine phosphatase 1B) [20], a promising target in the treatment of type-II diabetes and obesity [21], but also HIV-1 integrase [22].